CST3 and acute kidney injury: Serum cystatin C is a sensitive marker of AKI in a variety of patient populations(39, 40), and in an oncologic CAYA patient population, cystatin C has been described as a potential tool to detect eGFR changes earlier than sCr after an insult, with superior sensitivity for detecting minor changes in kidney function(38).